Abbott Rapid Dx North America LLC Respiratory Test Kit ID NOW™ Influenza A + B 2.0 Molecular Diagnostic Influenza A + B Nasal Swab / Nasopharyngeal Swab Sample 24 Tests CLIA Waived - KT/24 - 427000-KT
Abbott Rapid Dx North America LLC Respiratory Test Kit ID NOW™ Influenza A + B 2.0 Molecular Diagnostic Influenza A + B Nasal Swab / Nasopharyngeal Swab Sample 24 Tests CLIA Waived - KT/24 - 427000-KT
Regular price
$2,314.99
Sale price
$2,314.99
Regular price
Unit price
per
Shipping calculated at checkout.
50 In stock
Estimated deliver:
Flat-Rate Shipping from $8.25
Abbott Rapid Dx North America LLC Respiratory Test Kit ID NOW™ Influenza A + B 2.0 Molecular Diag...
| Item Id | 1081756 |
| MF Id# | 427000 |
| Brand | ID NOW™ Influenza A + B 2.0 |
| Manufacturer | Abbott Rapid Dx North America LLC |
| Country of Origin | United States |
| Application | Respiratory Test Kit |
| CLIA Classification | CLIA Waived |
| CLIA Classified | CLIA Waived |
| Contents 1 | Test Bases, Sample Receivers, Transfer Cartridges, Nasal Swabs, Positive and Negative Control Swabs, Plastic Disposable Pipettes, Product Insert and Quick Reference Instructions |
| For Use With | For ID Now™ Instrument US |
| Number of Tests | 24 Tests |
| Product Dating | McKesson Acceptable Dating: we will ship >= 90 days |
| Purchase Program Type | Standard Purchase |
| Reading Type | Machine Read |
| Sample Type | Nasal Swab / Nasopharyngeal Swab Sample |
| Specialty | Molecular |
| Test Format | Test Device Format |
| Test Name | Influenza A + B |
| Test Type | Molecular Diagnostic |
| Time to Results | 5 Minute Results (Positive), 13 Minute Results (Negative) |
| UNSPSC Code | 41116144 |
Features
- Alere I is now ID Now™
- Small footprint enables ease of use at point of care
- Simple operation via visual touchscreen
- Highly accurate results in 13 minutes
- Integrated pipette eliminates manual pipetting for direct samples
- Standardized respiratory trio (Influenza A & B, RSV, Strep) across all sites of care
- Bi-directional connectivity to industry leading RALS® platform facilitates satellite testing and remote management
- CLIA COMPLEXITY: WAIVED - For Direct Nasal Swabs (Not Eluted in Viral Transport Media) Only